Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| First Hospital of China Medical University | OTHER |
| First Affiliated Hospital Xi'an Jiaotong University | OTHER |
| Beijing Anzhen Hospital | OTHER |
| Xiangya Hospital of Central South University |
Not provided
Not provided
Not provided
Not provided
This is a multi-center randomized clinical trial study. The purpose of this study is to examine safety, feasibility and efficacy of automated peritoneal dialysis as compared with intermittent hemodialysis for AKI patients with indications for dialysis.
The incidence of acute kidney injury (AKI) is rapidly increasing worldwide. This is a common and devastating disorder, especially in critical illnesses, affecting 5-8% of all hospitalized patients and up to 30% of those in intensive care units, with high mortality. About 50-80% critical patients with AKI needed dialysis treatment. Intermittent hemodialysis (IHD) might be the most-commonly modalities applied in AKI patients requiring dialysis. However, no data of randomized study concerning renal recovery and treatment efficiency of AKI patients treated with APD is available in Chinese adult patients. This study is a 2-armed randomized controlled non-blind non-inferior trial to explore the feasibility, efficacy, and safety of APD in AKI patients as compared with intermittent hemodialysis. Base on the sample size estimation, 100 subjects (n=50 in each arm) should be enrolled in this study. The primary outcome is the rate of renal recovery (independence of dialysis) in the first 21days after initiation of renal replacement.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| APD group | Experimental | Subjects will receive PD catheter placement and subsequent automated peritoneal dialysis treatment. |
|
| IHD group | Active Comparator | Subjects will receive un-tunneled hemodialysis catheter placement and subsequent intermittent hemodialysis. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Automated peritoneal dialysis | Other | The prescription of automated peritoneal dialysis:
|
| Measure | Description | Time Frame |
|---|---|---|
| The rate of renal function recovery (independence of dialysis) | Patients do not require dialysis, urine output>1000ml/d and progressive drop in serum creatinine(<4mg/dl) and BUN(<50mg/dl). | At 21 days after the initiation of dialysis |
| Measure | Description | Time Frame |
|---|---|---|
| All-cause mortality within 21 days | The rate of all-cause of deaths at 21 days after the initiation of dialysis | At 21 days after the initiation of dialysis |
| All-cause mortality within 90 days |
Not provided
Inclusion Criteria:
AKI patients according to Acute Kidney Injury Network criteria
Rapidly rising serum creatinine level (a sudden increase of at least 30%)
Meeting the indications for dialysis
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Peng Xia, MD | Contact | +86-13811684903 | 7-xp@163.com | |
| Ying Wang, MD, PhD | Contact | +86-18600930725 | pumchwy@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Limeng Chen, MD, PhD | Division of Nephrology, Peking Union Medical College Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beijing Anzhen Hospital, Capital Medical University | Recruiting | Beijing | Beijing Municipality | 100029 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 16928612 | Background | Gabriel DP, Nascimento GV, Caramori JT, Martim LC, Barretti P, Balbi AL. Peritoneal dialysis in acute renal failure. Ren Fail. 2006;28(6):451-6. doi: 10.1080/08860220600781245. | |
| 18379555 | Background | Gabriel DP, Caramori JT, Martim LC, Barretti P, Balbi AL. High volume peritoneal dialysis vs daily hemodialysis: a randomized, controlled trial in patients with acute kidney injury. Kidney Int Suppl. 2008 Apr;(108):S87-93. doi: 10.1038/sj.ki.5002608. |
Not provided
Not provided
To comply with laws in China, local regulations and hospital policy, IPD sharing might be restricted
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D058186 | Acute Kidney Injury |
| ID | Term |
|---|---|
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
| OTHER |
| Baxter Healthcare Corporation | INDUSTRY |
Subjects eligible for this study will be randomized into APD group and IHD group. In APD group, subjects will receive PD catheter placement and subsequent APD treatment. In IHD group, subjects will receive un-tunneled hemodialysis catheter placement and subsequent hemodialysis.
Not provided
Not provided
Not provided
Not provided
|
| Intermittent hemodialysis | Other | Intermittent hemodialysis will be performed 3-4h of each session and 2-5 times per week. The prescription will be adjusted based on patients' conditions to ensure spKT/V≥1.3. |
|
The rate of all-cause of deaths at 90 days after the initiation of dialysis
| At 90 days after the initiation of dialysis |
| Access related complications within 21 days |
| At 21 days after the initiation of dialysis |
| Access related complications within 90 days |
| At 90 days after the initiation of dialysis |
| Dialysis related complications within 21 days | Hypotension, hypoglycemia, bleeding, reactions to dialyzers, etc | At 21 days after the initiation of dialysis |
| The percentage of participants requiring termination of primary dialysis modality | Condtions leading to termination of primary dialysis modality, including bleeding, thromboebolism events, infections, access related complications and inadequate dialysis | At 90 days after the initiation of dialysis |
| Length of stay in hospital | The time length of stay as an inpatient | From the time of admission to the time of discharge, up to 90 days |
| Herth Hope Index within 21 days | Measure hope of patients using Herth Hope Index. Total possible points on the total scale is 48 points. The higher the score the higher the level of hope. To each question, strongly agree=4, agree=3, disagree=2, strongly disagree=1. Note: the scoring items need to be reversed scored in question 3 and 6. | At 21 days after the initiation of dialysis |
| Health Status Questionnaire (Short Form-36) score within 21 days | Health Status Questionnaire (Short Form-36) is one of the most widely used generic measures of health-related quality of life and has been shown to discriminate between subjects with different chronic conditions and between subjects with different severity levels of the same disease.It generates 8 subscales and two summary scores. The 8 subscales are: physical functioning (Range 0-100), role limitations due to physical problems (Range 0-100), bodily pain (Range 0-100), general health perceptions (Range 0-100), vitality (Range 0-90), social functioning (Range 12.5-100), role-limitations due to emotional problems (Range 0-100), and mental health (Range 0-100). The two summary scores are the physical component summary (Range 13.6-61.9) and the mental component summary (Range 15.6-70.0). The higher the score is, the better quality of life of the patient is. | At 21 days after the initiation of dialysis |
| Mini-Mental State Examination (MMSE) score within 21 days | The Mini-Mental State Examination (MMSE) is a 30-point questionnaire that is used to measure cognitive impairment. The maximum score is 30. The following three cut-off levels should be employed to classify the severity of cognitive impairment: no cognitive impairment=24-30; mild cognitive impairment=18-23; severe cognitive impairment=0-17. | At 21 days after the initiation of dialysis |
| Simplified Nutritional Appetite Questionnaire (SNAQ) score within 21 days | Simplified Nutritional Appetite Questionnaire (SNAQ) ask the subject to complete answer 4 questions about the appetite. Tally the results based upon the following numerical scale: a=1, b=2, c=3, d=4, e=5. The sum of the scores for the individual items constitutes the SNAQ score. The maximum SNAQ score is 20. SNAQ score < 14 indicates significant risk of at least 5% weight loss within six months. | At 21 days after the initiation of dialysis |
| Peking Union Medical College Hospital | Recruiting | Beijing | Beijing Municipality | 100730 | China |
|
| Xiangya Hospital, Central South University | Recruiting | Changsha | Hunan | 410008 | China |
|
| The First Hospital of China Medical University | Recruiting | Shenyang | Liaoning | 110001 | China |
|
| The First Affiliated Hospital of Xi'an Jiaotong University | Recruiting | Xi'an | Shannxi | 710000 | China |
|
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |